Las Vegas Skin & Cancer Clncs is categorized under Dermatologists in Pahrump, NV .
Las Vegas Skin & Cancer Clncs was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lucios Blanchard at the company’s single location by writing to 2080 East Calvada Boulevard # 500, Pahrump, Nevada NV 89048 or by phoning (702) 933-0225. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Las Vegas Skin & Cancer Clncs |
| Contact Person: | Lucios Blanchard |
| Address: | 2080 East Calvada Boulevard # 500, Pahrump, Nevada 89048 |
| Phone Number: | (702) 933-0225 |
| Website Address: | lvscc.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Dermatologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Las Vegas Skin & Cancer Clncs was started in 0 to provide professional Dermatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Lucios Blanchard for inquiries that concern Las Vegas Skin & Cancer Clncs by calling the company number (702) 933-0225, as your correspondence is most welcome. Additionally, the physical location of the single location of Las Vegas Skin & Cancer Clncs can be found at the coordinates 36.19362,-115.97679 as well as the street address 2080 East Calvada Boulevard # 500 in Pahrump, Nevada 89048.
For its online presence, you may visit Las Vegas Skin & Cancer Clncs’s website at lvscc.com and engage with its social media outlets through on Twitter and on Facebook.